MYCO-006
MYCO-006 is an MDMA-like entactogen that is under development for the treatment of psychiatric disorders.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MYCO-006 is an MDMA-like entactogen that is under development for the treatment of psychiatric disorders. It is a short-acting and fast-onset MDMA analogue. Based on animal studies, it is predicted that MYCO-006 will have a duration of 1 to 2 hours, about one-third the 6- to 8-hour duration of MDMA, and to onset 4 times as fast as MDMA.
MYCO-006 is being developed by Mydecine. As of February 2024, it is in preclinical research. The chemical structure of MYCO-006 does not yet appear to have been disclosed. and were described in Mydecine's patent for short-acting MDMA analogues.
See also
MYCO-002 MYCO-007 List of investigational hallucinogens and entactogens
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372023298 under CC BY-SA 4.0; modifications have been made.